|Articles|June 24, 2016
Automation in Aseptic Processing
Advertisement
Chris Procyshyn, CEO of Vanrx, sat down with BioPharm International to discuss automation in aseptic processing.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
3
How Engineered Exosomes Can Impact Targeted Therapies
4
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
5
